Home/Filings/4/0001415889-24-001896
4//SEC Filing

Zojwalla Naseem 4

Accession 0001415889-24-001896

CIK 0001750284other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 7:30 AM ET

Size

7.0 KB

Accession

0001415889-24-001896

Insider Transaction Report

Form 4
Period: 2024-01-25
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-01-25$7.02/sh+20,000$140,40066,664 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-01-2520,000214,000 total
    Exercise: $7.02Exp: 2032-01-31Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001905871

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 7:30 AM ET
Size
7.0 KB